Robert J. Desnick

Affiliations: 
Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Area:
Genetics, Molecular Biology, Pathology
Google:
"Robert Desnick"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ortiz A, Kanters S, Hamed A, et al. (2021) Agalsidase beta treatment slows estimated glomerular filtration rate loss in classic Fabry disease patients: results from an individual patient data meta-analysis. Clinical Kidney Journal. 14: 1136-1146
Seo GH, Kim T, Choi IH, et al. (2020) Diagnostic yield and clinical utility of whole exome sequencing using an automated variant prioritization system, EVIDENCE. Clinical Genetics
Yasuda M, Huston MW, Pagant S, et al. (2020) AAV2/6 Gene Therapy in a Murine Model of Fabry Disease Results in Supraphysiological Enzyme Activity and Effective Substrate Reduction. Molecular Therapy. Methods & Clinical Development. 18: 607-619
Berger S, Stattmann M, Cicvaric A, et al. (2020) Severe hydroxymethylbilane synthase deficiency causes depression-like behavior and mitochondrial dysfunction in a mouse model of homozygous dominant acute intermittent porphyria. Acta Neuropathologica Communications. 8: 38
Gouya L, Ventura P, Balwani M, et al. (2019) EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks. Hepatology (Baltimore, Md.)
Parker CJ, Desnick RJ, Bissel MD, et al. (2019) Results of a pilot study of isoniazid in patients with erythropoietic protoporphyria. Molecular Genetics and Metabolism
Chen B, Whatley S, Badminton M, et al. (2019) International Porphyria Molecular Diagnostic Collaborative: an evidence-based database of verified pathogenic and benign variants for the porphyrias. Genetics in Medicine : Official Journal of the American College of Medical Genetics
Moghe A, Ramanujam VMS, Phillips JD, et al. (2019) Harderoporphyria: Case of lifelong photosensitivity associated with compound heterozygous coproporphyrinogen oxidase (CPOX) mutations. Molecular Genetics and Metabolism Reports. 19: 100457
Chen B, Solis-Villa C, Erwin AL, et al. (2019) Identification and characterization of 40 novel hydroxymethylbilane synthase mutations that cause acute intermittent porphyria. Journal of Inherited Metabolic Disease. 42: 186-194
Yasuda M, Desnick RJ. (2019) Murine models of the human porphyrias: Contributions toward understanding disease pathogenesis and the development of new therapies. Molecular Genetics and Metabolism
See more...